Candida parapsilosis: A systematic review to inform the World Health Organization fungal priority pathogens list

• Published in: Medical mycology (Oxford) 2024-06, Vol.62 (6)
• Main Authors: Asogan, Mrudhula, Kim, Hannah Yejin, Kidd, Sarah, Alastruey-Izquierdo, Ana, Govender, Nelesh P, Dao, Aiken, Shin, Jong-Hee, Heim, Jutta, Ford, Nathan Paul, Gigante, Valeria, Sati, Hatim, Morrissey, C Orla, Alffenaar, Jan-Willem, Beardsley, Justin
• Format: Article
• Language: English
• Subjects: Antifungal Agents - pharmacology; Antifungal Agents - therapeutic use; Candida parapsilosis - drug effects; Candidiasis - epidemiology; Candidiasis - microbiology; Cross Infection - epidemiology; Cross Infection - microbiology; Drug Resistance, Fungal; Humans; Incidence; Original; World Health Organization
• ISSN: 1369-3786; 1460-2709; 1460-2709
• DOI: 10.1093/mmy/myad131

Candida parapsilosis is globally distributed and recognised for causing an increasing proportion of invasive Candida infections. It is associated with high crude mortality in all age groups. It has been particularly associated with nosocomial outbreaks, particularly in association with the use of invasive medical devices such as central venous catheters. Candida parapsilosis is one of the pathogens considered in the WHO priority pathogens list, and this review was conducted to inform the ranking of the pathogen in the list. In this systematic review, we searched PubMed and Web of Science to find studies between 2011 and 2021 reporting on the following criteria for C. parapsilosis infections: mortality, morbidity (hospitalisation and disability), drug resistance, preventability, yearly incidence, and distribution/emergence. We identified 336 potentially relevant papers, of which 51 were included in the analyses. The included studies confirmed high mortality rates, ranging from 17.5% to 46.8%. Data on disability and sequelae were sparse. Many reports highlighted concerns with azole resistance, with resistance rates of >10% described in some regions. Annual incidence rates were relatively poorly described, although there was clear evidence that the proportion of candidaemia cases caused by C. parapsilosis increased over time. While this review summarises current data on C.parapsilosis, there remains an urgent need for ongoing research and surveillance to fully understand and manage this increasingly important pathogen.